DDMAC Letter Cites Pfizer Geodon Ad For Implying Superiority To Haloperidol
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA also points to the journal ad’s lack of discussion of specific warnings for metabolic side effects and movement disorders.